In humans, IL-17A expression has been reported in several tumor types, including ovarian cancer, prostate cancer, colon cancer, non–small cell lung cancer, hepatocellular carcinoma, gastric cancer and esophageal cancer [8], [9], [10], [11], [12], [13], [14]. Here, IL17A is linked to ovarian carcinoma.